Product
Otilimab
2 clinical trials
2 indications
Indication
ArthritisIndication
RheumatoidClinical trial
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid ArthritisStatus: Terminated, Estimated PCD: 2023-02-24
Clinical trial
A Single Center, Single Dose, Open-label Study in Healthy Japanese Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of OtilimabStatus: Withdrawn, Estimated PCD: 2023-05-04